AFRICA editorial towards developing guidelines and systems of care to facilitate early reperfusion for st-elevation myocardial infarction in africa Rhena Delport
An increase in cardiovascular disease (CVD) burden is also expected due to the increased prevalence and incidence of CVD risk factors, paucity of surveillance data and registries, lack of interventional measures, as well as a shortage of physicians and cardiologists, inadequate diagnostic capabilities, and misguided opinions. [6] [7] [8] Although CVD remains the leading cause of death in the world, 9 three-quarters of which occur in low-and middleincome populations, 6 the burden of ischaemic heart disease (IHD) remains low in comparison with other causes of heart disease, particularly in people of African descent. 6, 10, 11 Marked variability is however observed in the incidence, prevalence and mortality rates of IHD across developing countries, as in Africa, mainly due to the differences in composition and severity of risk factors and management thereof, as well as the stage of epidemiological transition. 6, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Concerted action among the WHO and international cardiac societies to improve cardiovascular health and prevent death from cardiovascular disease is increasingly becoming evident. 21, 22 Hopefully African societies will follow suit.
Current guidelines
The majority of recommendations in the European 23 and American 24 guidelines for the management of STEMI were perceived as either identical or overlapping. 25 The detail of the guidelines will not be replicated here, neither is the aim of this editorial to perform further comparisons with other international guidelines. A brief exposition on primary reperfusion strategies will be provided from random sources, with the emphasis on the African context where percutaneous coronary intervention (PCI) facilities are sparsely distributed and emergency medical services (EMS) are not readily available.
Primary percutaneous coronary intervention is the preferred and most effective option for reperfusion, provided that the intervention is performed timely by an experienced operator. 26, 27 Although performance metrics such as 'door-to-balloon time' or 'door-to-needle time' are employed to quantify time lapses from the onset of symptoms to definitive treatment, the concept of 'first medical contact (FMC)-to-device time' recognises the need for speedy diagnosis and treatment as the primary outcome. 26 The patient as well as factors relating to EMS determine the time delay between the onset of symptoms and the FMC, while FMC and the beginning of reperfusion is explained by EMS transport time to a PCI-capable facility and determinants of 'door-to-balloon' time. 27 Ideally the patient should be transported directly to a PCI-capable hospital for primary PCI but if the patient is admitted to a non-PCI facility, the door-in-door-out time should ideally be 30 minutes or less before the patient is transported to a PCI-capable hospital. 26 The FMC-to-device time should be 90 minutes or less, and in the case of necessity to transfer the patient for PCI, 120 minutes or less. If primary PCI is not achievable within 120 minutes thrombolytics should be administered with FMC within 30 minutes of diagnosis of STEMI either pre-hospital by a trained paramedic/clinic nurse, or, alternatively, by a physician in the nearest ER. 26, 27 Additional recommendations of relevance as proposed in the United Kingdom 'NICE' guidelines 28 
Current guidelines for remote areas
For the treatment of STEMI patients living in remote, sparsely populated areas with no ready access to PCI facilities, the pharmaco-invasive strategy is advocated. Fibrinolysis should be commenced as soon as possible if there are no contraindications, followed by transfer to a PCI facility for rescue PCI or angiography with possible PCI as a routine measure. Patients with contra-indications for fibrinolysis, late presenters, and patients with cardiogenic shock should be transferred to a PCI facility irrespective of the duration of transfer. Clear treatment protocols and a well-organised STEMI network are pivotal in STEMI management in these areas. 29 From the Australian experience, we learn that direct transport to PCI facilities and inter-hospital transfer for primary PCI positively impact on timely access to primary PCI (defined as 'the proportion of the population capable of reaching a PPCI facility ≤ 120 minutes from emergency medical services activation') and that pre-hospital fibrinolysis significantly improves timely access to reperfusion PCI (defined as 'the proportion of the population capable of reaching a fibrinolysis facility in ≤ 60 minutes from emergency medical services activation') in remote areas. 29 Geographical information systems were employed to integrate hospital, classified as hospitals that provided PCI or fibrinolysis, and population and road network data, 30 which in all probability contributes to informed management of STEMI care.
Concluding remark
In our endeavour to facilitate early reperfusion for ST elevation myocardial infarction in Africa we need to bear in mind that ' 
